Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
Clinical trial NCT04599634 · COMPLETED
Trial details
- NCT number
- NCT04599634
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2024-03-29
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.